C07D 497/22
In which the condensed system contains four or more hetero rings
Official title: in which the condensed system contains four or more hetero rings
C07D497/22 (In which the condensed system contains four or more hetero rings) appears on 18 US grants and 22 published applications in this corpus.
Search patents in C07D- Granted patents
- 18
- Published applications
- 22
- Assignees
- 19
- Inventors
- 79
- Latest grant
- 3 Jun 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1997 | 1 | 0 |
| 1998 | 0 | 0 |
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 2 |
| 2005 | 0 | 0 |
| 2006 | 0 | 1 |
| 2007 | 2 | 0 |
| 2008 | 1 | 1 |
| 2009 | 0 | 1 |
| 2010 | 0 | 0 |
| 2011 | 1 | 1 |
| 2012 | 0 | 0 |
| 2013 | 1 | 0 |
| 2014 | 0 | 1 |
| 2015 | 1 | 0 |
| 2016 | 1 | 0 |
| 2017 | 1 | 1 |
| 2018 | 0 | 1 |
| 2019 | 1 | 2 |
| 2020 | 1 | 1 |
| 2021 | 1 | 1 |
| 2022 | 2 | 2 |
| 2023 | 0 | 3 |
| 2024 | 2 | 1 |
| 2025 | 1 | 1 |
| 2026 | 0 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Macrocyclic fused pyrazoles as Mcl-1 inhibitors3 Jun 2025US 12,319,703 B2Ascentage Pharma Group Corp Limited
- Bridged tricyclic carbamoylpyridone compounds and uses thereof6 Aug 2024US 12,054,496 B2Gilead Sciences, Inc.
- Bridged tricyclic carbamoylpyridone compounds and uses thereof2 Jul 2024US 12,024,528 B2Gilead Sciences, Inc.
- Hexacyclic heteroaromatic compounds for electronic devices27 Dec 2022US 11,535,619 B2Merck Patent GmbH
- Mcl-1 inhibitors and methods of use thereof18 Oct 2022US 11,472,816 B2AstraZeneca AB
- Compound for organic photoelectric element, organic photoelectric element, image sensor and electronic device comprising the same8 Oct 2026US 2026/0314261 A1Duk San Neolux Co., Ltd.
- Pharmaceutical composition comprising lurbinectedin, preparation method therefor, and use thereof23 Jul 2026US 2026/0207586 A1BrightGene Bio-Medical Technology Co., Ltd.
- Bridged tricyclic carbamoylpyridone compounds and uses thereof10 Apr 2025US 2025/0115620 A1Gilead Sciences, Inc.
- Targeted protein degradation using bifunctional compounds that bind ubiquitin ligase and target mcl-1 protein5 Sep 2024US 2024/0294499 A1
- Bridged tricyclic carbamoylpyridone compounds and uses thereof26 Oct 2023US 2023/0339971 A1Gilead Sciences, Inc.
Most cited
By later US patents
- Heteroatom-functionalized porphyrazines and multimetallic complexes and polymers derived therefrom24US 5,675,001 AHoffman/Barrett, L.L.C. · 1997
- Heteroatom-functionalized porphyrazines and multimetallic complexes and polymers derived therefrom18US 5,912,341 AHoffman/Barrett, L.L.C. · 1999
- Antitumoral analogs of ET-74318US 7,410,969 B2Pharma Mar, S. A. · 2008
- Antitumoral analogs of et-74316US 7,247,629 B2Pharma Mar, S.A. · 2007
- Lyotropic liquid crystal systems based on perylenetetracarboxylic acid dibenzimidazole sulfoderivatives, related anisotropic films, and methods for making10US 7,160,485 B2Nitto Denko Corporation · 2007